Atomized Inhalation ICG for Treatment of Congenital Lung Malformations
Recruiting
N/A
Interventional Study
Pulmonary Sequestration
Congenital Pulmonary Airway Malformation
Indocyanine Green
Thoracoscopic Surgery
Children
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 3 Months – 14
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Jiexiong Feng · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To investigate the safety and effectiveness of preoperative aerosol inhalation ICG solution for thoracoscopic accurate resection of congenital lung malformations in children.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* children with congenital lung malformations diagnosed by CT or MRI scan
Exclusion Criteria:
* 1\. ages \<3 months and \>14 years 2. complicated other life-threatening disease; 3. complicated severely pulmonary infection
Contacts